Cocrystal Pharma
Patents, Design & Utilities
Last updated:
List of all Cocrystal Pharma patents 11 in total
| Status | Patent |
|---|---|
Application | Utility: PYRIDOPYRAZINE AND PYRIDOTRIAZINE INHIBITORS OF INFLUENZA VIRUS REPLICATION Filling date: 26 Sep 2025 Issue date: 24 Feb 2022 |
Application | Utility: INHIBITORS OF INFLUENZA VIRUS REPLICATION Filling date: 26 Sep 2025 Issue date: 17 Feb 2022 |
Application | Utility: FORMULATIONS OF INFLUENZA THERAPEUTICS Filling date: 26 Sep 2025 Issue date: 23 Dec 2021 |
Application | Utility: COMBINATIONS OF INHIBITORS OF INFLUENZA VIRUS REPLICATION Filling date: 26 Sep 2025 Issue date: 18 Nov 2021 |
Application | Utility: COMBINATION THERAPY FOR TREATMENT OF HCV Filling date: 26 Sep 2025 Issue date: 3 Jun 2021 |
Grant | Utility: Pyrrolopyrimidine derivatives useful as inhibitors of influenza virus replication Filling date: 26 Sep 2025 Issue date: 25 May 2021 |
Application | Utility: PYRROLO[2,3-B]PYRIDIN DERIVATIVES AS INHIBITORS OF INFLUENZA VIRUS REPLICATION Filling date: 26 Sep 2025 Issue date: 29 Apr 2021 |
Grant | Utility: Inhibitors of Hepatitis C virus polymerase Filling date: 26 Sep 2025 Issue date: 16 Mar 2021 |
Application | Utility: INHIBITORS OF HEPATITIS C VIRUS POLYMERASE Filling date: 26 Sep 2025 Issue date: 13 Aug 2020 |
Application | Utility: PYRROLOPYRIMIDINE DERIVATIVES USEFUL AS INHIBITORS OF INFLUENZA VIRUS REPLICATION Filling date: 26 Sep 2025 Issue date: 23 Apr 2020 |
Grant | Utility: Inhibitors of hepatitis C virus polymerase Filling date: 26 Sep 2025 Issue date: 5 Nov 2019 |
Showing 1 to 11 of 11 patents.